Total Funding
3
Total FundingPost-IPO Debt raised
Growth Score
pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
702165
Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis.
Acquired by 
Pacira Pharmaceuticals
David A. Arkowitz: Chief Financial OfficerPast Role: Mascoma, Chief Financial Officer and General Manager, Mascoma Grain Tech
Christina Willwerth: Chief Strategy OfficerPast Role: Flexion Therapeutics, Vice President, Clinical Operations & Program Management
About the Company
Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.
